Old Web
English
Sign In
Acemap
>
authorDetail
>
Max Wilberding
Max Wilberding
Ohio State University
Cancer research
Drug resistance
FGFR Inhibition
Erdafitinib
Immunology
2
Papers
54
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.
2020
British Journal of Cancer
Melanie A. Krook
Julie W. Reeser
Gabrielle Ernst
Hannah Barker
Max Wilberding
Gary Li
Hui-Zi Chen
Sameek Roychowdhury
Show All
Source
Cite
Save
Citations (18)
Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma
2020
Molecular Cancer Therapeutics
Melanie A. Krook
Alexandria M. Lenyo
Max Wilberding
Hannah Barker
Mikayla Dantuono
Kelly M. Bailey
Hui-Zi Chen
Julie W. Reeser
Michele R. Wing
Jharna Miya
Eric Samorodnitsky
Amy M. Smith
Thuy Dao
Dorrelyn M. Martin
Kristen K. Ciombor
John L. Hays
Aharon G. Freud
Sameek Roychowdhury
Show All
Source
Cite
Save
Citations (36)
1
map